Product / Antineoplastic

PEMIREX

1.) Pemetrexed in combination with cisplatin is indicated for the treatment of chemotherapy naïve patients with unresectable malignant pleural mesothelioma. 2.) Pemetrexed in combination with cisplatin is indicated for the first-line treatment of patients with locally advanced or metastatic non-small cell lung cancer other than predominantly squamous cell histology. 3.) Pemetrexed is indicated as monotherapy for the maintenance treatment of locally advanced or metastatic non-small cell lung cancer other than predominantly squamous cell histology in patients whose disease has not progressed immediately following platinum-based chemotherapy. 4.) Pemetrexed is indicated as monotherapy for the second-line treatment of patients with cally advanced or metastatic non-small cell lung cancer other than predominantly squamous cell histology.

Product / Antineoplastic

ALCAVIXIN

Acute leukemia; also in combination with other antineoplastic agents for Hodgkin's disease, lymphatic sarcoma, reticulum cell granuloma, rhabdomyosarcoma, neuroblastoma and Wilm's tumor.

Product / Antineoplastic

AXIBIN

Malignant lymphoma (lymphomas of both Hodgkin and non Hodgkin types, lymphoma sarcoma) gastric, hepatic,rectal and colic carcinoma, pangcreatic carcinoma, acute myeloplastic leukemia, soft-tissue and osteogenic sarcomas, breast, and ovarian carcinoma, lung, and bronchogenic carcinoma, bladder carcinoma, Wilms' carcinoma.

Product / Antineoplastic
(Cell Cycle-Specific Agent)

BLOICIN-S

- Squamous cell carcinoma : Head and neck, penis, cervix, and vulva. - Lymphomas ; Hodgkin's or non-Hodgkin's disease - Testicular carcinoma - For the treatment of malignant pleural effusion and prevention of recurrent pleural effusion.

Product / Antineoplastic

CAPMERIN

For treatment or maintenance therapy in acute leukemia, in acute lymphoblastic leukemia and acute myelogenous leukemia.

Product / Antineoplastic

CARBOTINOL 150mg

Advanced ovarian carcinoma of epithelial origin in first-line therapy and second-line therapy after other treatments have failed; small cell carcinoma of the lung.

Product / Antineoplastic

CARBOTINOL 450mg

Advanced ovarian carcinoma of epithelial origin in first-line therapy and second-line therapy after other treatments have failed; small cell carcinoma of the lung.

Product / Antineoplastic
(Cell Cycle-Nonspecific Agent)

CYTOSPLAT

Treatment of metastatic testicular tumors, metastatic ovarian tumors, advanced bladder carcinoma; testicular and ovarian neoplasms, head and neck cancer, cervical carcinoma, lung cancer.

Product / Antineoplastic

DUTICIN

Metastatic malignant melanoma; Hodgkin's disease; neuroblastoma; soft tissue sarcoma including leiomyosarcoma.

Product / Antineoplastic

ETOPUL

Small cell lung canser, lymphosarcoma, acute leukemia, testicular tumor, bladder cancer.

Product / Antineoplastic

GEMTABIN

Non-Small Cell Lung Cancer: Gemcitabine is indicated in combination with cisplatin for the first-line treatment of patients with inoperable, locally advanced (Stage IIIA or IIIB), or metastatic (Stage IV) non-small cell lung cancer. Pancreatic Cancer: Gemcitabine is indicated as first-line treatment for patients with locally advanced (nonresectable Stage II or Stage III) or metastatic (Stage IV) adenocarcinoma of the pancreas. Gemcitabine is indicated for patients previously treated with 5-FU.

Product / Anti-estrogen

GYRAXEN

For the treatment of advanced breast cancer in postmenopausal women.

Product / Antineoplastic

IPHOX 1g

Inoperable malignant tumors which are susceptible to an Ifosfamide treatment, e.g. bronchial carcinoma, ovarian carcinoma, testicular tumors, sarcoma of soft parts, mammary carcinoma, pancreatic carcinoma, hypernephroma,endometrial carcinoma; malignant lymphoma.

Product / Antineoplastic

IPHOX 2g

Inoperable malignant tumors which are susceptible to an Ifosfamide treatment, e.g. bronchial carcinoma, ovarian carcinoma, testicular tumors, sarcoma of soft parts, mammary carcinoma, pancreatic carcinoma, hypernephroma,endometrial carcinoma; malignant lymphoma.

Product / Antineoplastic

KRABINEX

Melanoma, resistant chronic myelocytic leukemia, and recurrent,metastatic, or inoperable carcinoma of the ovary. Local control of primary squamous cell (epidermoid) carcinomas of the head and neck, excluding the lip.

Product / Antidote for folic Acid Antagonist

LITACOR

Indicated to diminish the toxicity and counteract the effects of inadvertent over dosages of folic acid antagonists; also for use in combination with 5-fluorouracil to prolong survival in the palliative treatment of patients with advanced colorectal cancer.

Product / Antineoplastic

MYTOXID

Used to improved subjective and objective symptoms in a wide range of neoplastic conditions including chronic lymphatic leukemia, chronic myelocytic leukemia, gastric cancer, colonic and rectal cancer, pulmonary cancer, pancreatic cancer, mastocarcinoma, tumor of the head & neck, bladder tumor.

Product / Antineoplastic

NEOQUABIN 50mg

Epirubicin has produced responses in a wide range of neoplastic conditions, including breast, ovarian, gastric, lung, liver, and colorectal carcinomas, malignant lymphomas, leukemias, multiple myeloma and Soft tissue sarcoma.

Product / Antineoplastic

NEOQUABIN 10mg

Epirubicin has produced responses in a wide range of neoplastic conditions, including breast, ovarian, gastric, lung, liver, and colorectal carcinomas, malignant lymphomas, leukemias, multiple myeloma and Soft tissue sarcoma.

Product / Antineoplastic

NEWTAXEL-A

For the treatment of locally advanced (stage IIIA-IIIB) or metastatic (stage IV) breast cancer after previous chemotherapy failure, with Trastuzumab as initial therapy for metastatic disease that over-expresses Human Epidermal Growth Factor Receptor 2 (HER@), and with Doxorubicin and Cyclophosphamide for adjuvant treatment of operable node positive disease.

Product / Antineoplastic

PLATINOX

Oxaliplatin is used in combination with infusional 5-FU/LV, for treatment of advanced carcinoma of the colon or rectum and stage III colon cancer patients who have undergone complete resection of the primary tumor.

Product / Antineoplastic

PTERIN

It is used to produce regression in a wide range of neoplastic conditions including acute leukemis, non-Hodgkin's lymphomas, soft tissue and osteogenic sarcomas and solid tumors particularly breast, lung, head and neck, bladder, cervical.ovarian and testicular carcinoma. Also in the treatment of severe, uncontrolled psoriasis which is not responsive to the therapy.

Product / Antineoplastic

STRAZOL

Anastrozole is indicated for the treatment of breast cancer in postmenopausal women.

Product / Antipyretic/Analgesic

SUPERCET

It is indicated for the symptomatic of moderate to severe pain..

Product / Antineoplastic

TABINE

Gastric cancer, cholecyst cancr, bilianry tract cancer, pancreatic cancer, hepatocarcinoma, colonic cancer, rectal cancer, pulmonary cancer, mastocarcinoma, hysterocarcinoma, ovarian cancer. For induction of clinical remission and/or maintenance therapy in acute myeloid leukemia, acute non-lymphoblastic leukemia, acute lymphoblastic leukemia, blast crisis of chronic myeloid leukemia, diffuse histiocytic lymphomas.

Product / Antineoplastic

TREPAR

Wilm's tumor; rhabdomyosarcoma; carcinoma of testis and uterus; other neoplasms.

Product / Antineoplastic

UNITAXEL

Metastatic carcinoma of the ovary or breast, after failure of standard therapy.

Product / Adjunct to Antineoplastic Chemotherapy

UROMES

Prevention of urothelial toxicity of oxazaphosphorines, Ifosfamide and Cyclophosphamide.

Product / Antineoplastic

UTORAL

Palliative treatment of carcinoma of the colon, rectum, breast, stomach, and pancreas; also as adjunct to surgery for the treatment of various solid tumors; treatment of sarcoma: Hodgkin's disease, reticulosarcoma, fibrosarcoma, lympho-sarcoma.

Product / Antineoplastic

VELBASTINE

Treatment of Hodgkin's disease (stages III and IV); lymphocytic lymphoma; histiocytic lymphoma; advanced stage of mycosis fungoides; advanced carcinoma of the testis; Kaposi's sarcoma and histiocytosis X. Treatment of choriocarcinoma resistant to other chemothrapeutic agents; carcinoma of the breast.

Product / Antineoplastic

XELTABINE

Capecitabine is given orally for the treatment of metastatic colorectal cancer and is also used for the adjuvant treatment of patients after surgery for Dukes C colon Cancer. It is also used in the treatment of metastatic breast cancer.